A Double Blind Prospective Study of Metformin vs. Placebo in Overweight or Obese Post-menopausal Women at Elevated Risk for Breast Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Breast cancer; Obesity
- Focus Biomarker; Pharmacodynamics
- 30 Mar 2018 Biomarkers information updated
- 17 Apr 2013 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.